| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Feb―13 |
In-silico evaluation of the efficacy of essential oils from Artemisia absinthium,
Artemisia herba-alba, and Artemisia annua against SARS-CoV-2 |
Nawel Bouzerea |
| 2 |
[GO] |
2025―Dez―28 |
Characterization of COVID-19 patients in clinical, epidemiological, and
laboratory settings: the role of vitamin D binding protein and vitamin D level in
severity |
Aleen Sardar Al-Noori |
| 3 |
[GO] |
2025―Dez―06 |
Vaccination and vitamin D in relation to disease severity and mortality in patients
with COVID-19 disease: a follow-up study |
Aleen Sardar Al-noori |
| 4 |
[GO] |
2025―Jul―06 |
Interplay of upper respiratory tract microbiota, ımmune response, and molecular
dynamics in SARS-CoV-2 infection |
Sahar Abdul Wahhab Alsamarai |
| 5 |
[GO] |
2025―Mai―26 |
COVID-19 clinical outcomes and N-acetylcysteine (CoViNAC study): a GRADE
compliant meta-analysis of randomized controlled trials with molecular docking
and dynamics simulation studies with Mpro of SARS-CoV-2 |
Seshadri Reddy Varikasuvu |
| 6 |
[GO] |
2025―Feb―06 |
Association of interleukin polymorphisms and inflammatory markers with
hospitalization, survival, and COVID-19 severity in type 1 diabetes patients: A
multivariate and Cox regression analysis |
Mohammed Yousif Abdullah |
| 7 |
[GO] |
2025―Jan―12 |
The impact of COVID-19 infection on thyroid function |
Esraah Alharris |
| 8 |
[GO] |
2024―Dez―21 |
Impact of COVID-19 infection on cyclooxygenase-2 gene expression and mast cell
count in testicular tissue of azoospermic men |
Zahra Kalhor |
| 9 |
[GO] |
2024―Nov―28 |
Dominance of SARS-CoV-2 Delta AY.33 sublineage and Omicron BA.1.1
sublineage in Erbil city/Kurdistan region of Iraq |
Sazan Moffaq Abdulaziz |
| 10 |
[GO] |
2024―Okt―09 |
Assessment of immunological factors in COVID-19 patients treated by
convalescent plasma |
Mozhdeh Heidari |
| 11 |
[GO] |
2024―Sep―12 |
Anti- COVID-19 drug discovery by flavonoid derivatives: an extensive
computational drug design approach |
Subhasis Banerjee |
| 12 |
[GO] |
2024―Sep―12 |
Expression of antigen-presenting cells in lung of postmortem SARS-CoV-2 cases |
Taban Kamal Rasheed |
| 13 |
[GO] |
2024―Sep―12 |
Investigation of the potential molecular mechanisms of acupuncture in the
treatment of long COVID: a bioinformatics approach |
Ying Xu |
| 14 |
[GO] |
2024―Jun―05 |
Genetic analysis of SARS-CoV-2 spike gene using next generation sequencing
from COVID-19 patients in Erbil/Iraq |
Asma Ameen Ghareeb |
| 15 |
[GO] |
2024―Feb―19 |
SARS-CoV-2 receptor a distinct genetic profile specific to the Iraqi Kurdish
population |
Suhad Asaad Mustafa |
| 16 |
[GO] |
2024―Jan―27 |
Analysis of the expression and significance of lymphocyte ratio in different stages and clinical types of COVID-19 |
Jinwei Xu |
| 17 |
[GO] |
2023―Nov―28 |
Genomic analysis of SARS-CoV-2 omicron sublineage BA.5.2.1 in Erbil/ Iraq |
Sevan Omer Majed |
| 18 |
[GO] |
2023―Okt―09 |
The impact of COVID-19 on BNP, NT-proBNP and ANP in heart failure |
Rawaz D. Tawfeeq |
| 19 |
[GO] |
2023―Sep―17 |
Transcriptomic analysis in renal cell carcinoma and COVID-19 patients |
Maha Abdulla Alwaili |
| 20 |
[GO] |
2023―Sep―17 |
Recombinant Antibodies to Face SARS-CoV-2 Syndemic |
Maykel González Torres |
| 21 |
[GO] |
2023―Aug―12 |
The vitamin D binding protein gene polymorphism association with Covid-19-infected Iraqi patients |
Nawres Adnan Abdulameer |
| 22 |
[GO] |
2023―Jun―10 |
Comparison of Antibody Levels Produced by Pfizer, AstraZeneca, and Sinopharm Vaccination in COVID-19 Patients in Erbil City-Iraq |
Sevan Omer Majed |
| 23 |
[GO] |
2023―Mai―24 |
The importance of serum homocysteine as a biomarker in diabetic and obese COVID-19 patients |
Haitham Shawkat Ahmed |
| 24 |
[GO] |
2023―Mai―24 |
Hematological, immunological, and inflammation markers in patients of COVID-19 |
Fakhir Najim K. Sabir |
| 25 |
[GO] |
2022―Okt―13 |
Molecular interaction of cryptophycin 52 with Caspase 8 for the management of lung cancer during coronavirus outbreak: A computational study |
Leena Hussein Bajrai |
| 26 |
[GO] |
2022―Aug―21 |
Frailty is an Independent Determinant of COVID-19 Vaccine Hesitancy in the Elderly: a Cross-sectional Study |
Lu Xiong |
| 27 |
[GO] |
2022―Feb―04 |
Comparative Computational Analysis of Dirithromycin and Azithromycin in Search for a Potent Drug against COVID-19 caused by SARS-CoV-2: Evidence from molecular docking and dynamic simulation |
Kadri Adel, Mosbah Amor, Redissi Alaeddine, Noumi Emira, Alreshidi Mousa, Aouadi Kaïss, Ghannay Siwar, Siddiqui Arif Jamal, Adnan Mohd, Vincenzo De Feo, Snoussi Mejdi |
| 28 |
[GO] |
2022―Feb―04 |
Re-positive PCR of SARS-CoV-2 in health care persons during COVID-19 pandemic |
Masoud Alebouyeh, Pooya Aavani, Nareen Arif Abdulrahman, Azad Abduljabar Haleem, Abdollah Karimi, Shahnaz Armin, Fatemeh Fallah, Arezu Amirali, Saeed Sadr, Ghazaleh Ghandchi, Nafiseh Abdollahi, Roxana Mansour Ghanaie, Sedigheh Rafiei Tabatabaei, Seyed Alireza Fahimzad, Raheleh Razmara, Khalid J. Alzahrani, Ghamartaj Khanbabaee, Soheila Sadat Vaghefi, Farid Imanzadeh, Peyman Eshghi, Leila Azimi |
| 29 |
[GO] |
2022―Feb―04 |
Repurposing of anisomycin and oleandomycin as a potential anti-(SARS-CoV-2) virus targeting key enzymes using virtual computational approaches |
Rafat Zrieq, Mejdi Snoussi, Fahad D. Algahtan, Munazzah Tasleem, Mohd Saeed, Emira Noumi, Nasrin E. Khalifa, Mohamed A. M. Gad-Elkareem, Kaïss Aouadi, Adel Kadri |
| 30 |
[GO] |
2022―Jan―10 |
Tripeptides from Allium subhirsitum L. extracts: Pharmacokinetics properties, toxicity prediction and in silico study against SARS-CoV-2 enzymes and pro-inflammatory proteins |
Mejdi Snoussi, Emira Noumi, Amor Mosbah, Alaeddine Redissi, Mohd Saeed, Munazzah Tasleem, Mousa Alreshidi, Mohd Adnan, Ayshah Al-Rashidi, Arif Jamal Siddiqui, Kaïss Aouadi, Vincenzo De Feo, Adel Kadri |
| 31 |
[GO] |
2020―Dez―08 |
Lymphocyte cell population as a potential hematological index for early diagnosis of COVID-19 |
Yihua Zhu, XingJian Cao, Yonghui Lu, Dongsheng Xu, Renfei Lu, Xinling Li |
| 32 |
[GO] |
2020―Dez―08 |
A comprehensive review of histopathological findings of infections induced by COVID-19 |
Salah Tofik Jalal Balaky, Sahar Mohammed Zaki Abdullah, Markov Alexander, Marwah Suliman Maashi, Ayad F. Alkaim, Sara Shahriyari, Fariba Tabari, Elham Kazemi |
| 33 |
[GO] |
2020―Okt―12 |
Interleukin-6 role in the severity of COVID-19 and intensive care unit stay length |
Ruqaya Muhammed Ghareeb Taher Al barzin, Shler Ghafour Raheem, Pinar Khalid Khudhur, Rahim Abdulkarimi, Esmaeil Mohammadnejad, Amir Tabatabaee |
| 34 |
[GO] |
2020―Okt―12 |
Diagnostic and methodological evaluation of studies on the urinary shedding of SARS-CoV-2, compared to stool and serum: A systematic review and meta-analysis |
Mohammad Reza Roshandel, Masoud Nateqi, Ramin Lak, Pooya Aavani, Reza Sari Motlagh, Shahrokh F. Shariat, Tannaz Aghaei Badr, John Sfakianos, Steven A Kaplan, Ashutosh K Tewari |
| 35 |
[GO] |
2020―Jun―15 |
Combating sars-cov-2 through lipoxins, proteasome, caveolin and nuclear factor-κb pathways in non-pregnant and pregnant populations |
Onder Celik, Nilufer Celik, Suleyman Aydin, Bora Baysal, Suna Aydin, Aylin Saglam, Yagmur Gursu, Semih Dalkilic, Mustafa Ulas, Mustafa D Ozcil, Ahter T Tayyar, Ferhat Cengiz, Kader Ugur, Ramazan Fazil Akkoc, Aynur A Ersahin |
